Clarification

09/30/2004

Due to a lack of clarity in the original news report, a summary in Monday's FDLI SmartBrief stated that Purdue Pharma said Palladone, its recently approved analgesic, may be more difficult to misuse than OxyContin. Purdue Pharma says it does not claim that Palladone, which has been approved by the FDA, is abuse-resistant or more difficult to misuse than OxyContin.

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park